`
`US006797724B2
`
`US 6,797,724 B2
`(10) Patent No.:
`(12) United States Patent
`Etchegaray et al.
`(45) Date of Patent:
`Sep. 28, 2004
`
`
`(54) DIRECT SPOT-ON ANTIPARASITIC SKIN
`SOLUTION FOR DOMESTIC ANIMALS
`
`(75)
`
`Inventors: Jean-Pierre Etchegaray, Toulouse
`(FR); Philippe Jeannin,Tournefeuil1e
`(FR)
`
`10/1996 Senbo
`5,567,429 A
`3/1999 Jeannin
`5,885,607 A
`12/1999 Jeannin
`6,001,384 A
`1/2000 E_¢°'1°83T3Y
`520101710 A
`7/2001 11" 9”‘-
`°»7-55»‘‘3° 31 ‘
`FOREIGN PATENT DOCUMENTS
`
`(73) Assignee: Merial, Lyons (FR)
`
`EP
`
`0 295 117 A1
`
`12/1988
`
`( “‘ ) Notice:
`
`Subject to any disclaimer, the term of this
`patent is extended or adjusted under 35
`U.S.C. 154(b) by 0 days.
`
`(21) Appl. No.: 10/120,691
`
`(22) Filed:
`
`Apr. 11, 2002
`
`(65)
`
`Prior Publication Data
`US 2002/0155147 A1 Oct. 24, 2002
`
`Related U.S. Application Data
`
`(60) Division of application No. 09/450,186, filed on Nov. 29,
`1999, which is a continuation-in—part of application No.
`08/933,016, filed on Sep. 18, 1997, now Pat. No. 6,010,710,
`which is a continuation-in-part of application No. 08/692,
`178, filed on Aug. 5, 1996, now abandoned, and a continu-
`ation-in-part of application No. 09/051,693, filed as appli-
`cation No. PCT/FR97/01504 on Aug. 19, 1997, now Pat. No.
`6,001,384.
`
`(30)
`
`Foreign Application Priority Data
`
`Mar. 29, 1996
`Aug. 20, 1996
`Mar. 26, 1997
`
`(FR)
`(FR)
`(FR)
`
`.......................................... .. 96 04209
`
`96 10312
`.......................................... .. 97 03708
`
`Int. Cl.7 .............................................. .. A01N 43/56
`(51)
`(52) US. Cl.
`..................... .. 510407; 514/404; 514/406;
`424/405; 424/406; 424/407
`(58) Field of Search ................................. 514/341, 346,
`514/404, 406, 407
`
`(56)
`
`References Cited
`U.S. PATENT DOCUMENTS
`
`4,963,575 A
`5,232,940 A
`5,516,787 A
`
`10/1990 Buntain et :11.
`8/1993 Hatton et al.
`5/1996 Takada
`
`* cited by examiner
`
`Primary Examz'ner—Neil S. Levy
`(74) Attomey, Agent, or Firm—Frommer Lawrence &
`Haug LLP; Thomas J. Kowalski; Mark W. Russell
`
`(57)
`
`ABSTRACT
`
`A spot-on composition for the treatment or protection of a
`domestic animal against parasitic infestation comprising,
`
`(a) an insecticidal active substance of the formula (X):
`
`(X)
`
`H2N(S)C
`
`5(0)CF3
`
`\
`
`/
`"\ N
`
`C1
`
`NH:
`
`C1
`
`(b) an organic solvent; and
`
`(c) a vehicle; and
`
`(d) an emollient; wherein the composition comprises from
`0.05 to 25% weight/volume of the compound of formula
`(X), and the compound of formula (X) is applied in a dose
`between 0.1 and 2 mg/kg animal weight.
`
`25 Claims, 2 Drawing Sheets
`
`
`
`:91.
`
`TREATED 0.25%
`
`urawen 05.16
`
`:9:
`TREATE)1%_
`
`120
`
`11!)
`
`B888
`
`o
`
`Exhibit 1020A
`
`Merial v. Virbac
`
`IPR2014-01279
`
`
`
`U.S. Patent
`
`Sep. 28,2004
`
`Sheet 1 0f2
`
`US 6,797,724 B2
`
`120
`
`.20
`
`10.0
`
`80
`
`60
`
`40
`
`024 WO12141618202224161820
`
`TREATED 0,25%
`
`TREATED 0.5%
`
`TREATED 1%
`
`CONTROL
`
`FIG. 1
`
`
`
`
`
`U.S. PatentU.S. Patent
`
`
`
`Sep. 28,2004Sep. 28,2004
`
`
`
`Sheet 2 of2Sheet 2 of2
`
`
`
`US 6,797,724 B2US 6,797,724 B2
`
`
`
`500500
`
`
`
`400400
`
`
`
`300300
`
`
`
`200200
`
`
`
`''
`
`
`
`100100
`
`
`
`1
`DIRECT SPOT-ON ANTIPARASITIC SKIN
`SOLUTION FOR DOMESTIC ANIMALS
`
`2
`U.S. Pat. No. 5,885,607, issued to Jeannin on Mar. 23,
`1999;
`
`US 6,797,724 B2
`
`This application is a divisional of application Ser. No.
`09/450,186, filed Nov. 29, 1999, which continuation-in—part
`of U.S. application Ser. No. 08/933,016, filed Sep. 18, 1997,
`now allowed, which is in turn a continuation-in-part of
`application U.S. Ser. No. 08/692,178, filed Aug. 5, 1996,
`now abandoned, which claims priority to, French patent
`application No. 96 04 209 filed Mar. 29, 1996, and French
`patent application No. 97 03 708 filed Mar. 26, 1997; and
`this application is also a continuation-in-part of U.S. appli-
`cation Ser. No. 09/051,693, filed Jul. 27, 1998, now allowed,
`which in turn is the National Phase of International Appli-
`cation PCT/FR97/01504 having an international filing date
`of Aug. 19, 1997, and designating the U.S. and claiming
`priority from French patent application No. 96 10 312, filed
`Aug. 20, 1996.
`Reference is also made to: U.S. application Ser. No.
`09/271,470 filed Mar. 17, 1999, now pending, which is a
`continuation-in-part of lntemational Application PCT/
`FR97/01548, having an international filing date of Sep. 15,
`1997 and designating the U.S., and claiming priority to
`French application No. 96 11 446 filed Sep. 19, 1996; U.S.
`application Ser. No. 09/376,736, filed Aug. 17, 1999, now
`pending, which is a continuation-in-part of U.S. application
`Ser. No. 09/271,470 filed on Mar. 17, 1999, now pending,
`which is a continuation-in-part of International Application
`PCT/FR97/01548, having an international filing date of Sep.
`15, 1997 and designating the U.S., and claiming priority to
`French application No. 96 11 446 filed Sep. 19, 1996; US.
`application Ser. No. 09/381,794, filed Sep. 24, 1999, now
`pending, which in turn is the National Phase of lntemational
`Application No. PCT/FR98/00601 having an international
`filing date of Mar. 25, 1998 and designating the U.S., and
`claiming priority to French application No. 97 03 709, filed
`Mar. 26, 1997; U.S. application Ser. No. 08/891,047, filed
`Jul. 10, 1997, now pending, which claims priority from
`French application No. 96 08 703 filed Jul. 11, 1996 and
`French application No. 97 03 025 filed Mar. 13, 1997; U.S.
`application Ser. No. 08/863,692 filed Mar. 27, 1997, now
`allowed, which is a continuation—in-part of US application
`Ser. No. 08/692,113 filed Aug. 5, 1996, now abandoned,
`which claims priority to French patent application 96 04
`208, filed Mar. 29, 1996 and French application No. 97 03
`711 filed Mar. 26, 1997; U.S. application Ser. No. 08/719,
`942 filed Sep. 25, 1996, which claim priority to French
`application No. 95 11 685 filed Sep. 29, 1995 and French
`application No. 96 11 278 filed Sep. 11, 1996; and U.S.
`application Ser. No. 09/174,598 filed Oct. 19, 1998, now
`pending, which is a divisional application of U.S. applica-
`tion Ser. No. 08/863,182 filed Mar. 27, 1997, now U.S. Pat.
`No. 5,885,607, which is a continuation-in—part of U.S.
`application Ser. No. 08/692,430 filed Aug. 5, 1996, now
`abandoned, and which claims priority to French application
`No. 96 04 206 filed Mar. 29, 1996 and French application
`No. 97 03 707 filed Mar. 26, 1997.
`Each of the herein cited patent applications, and all
`documents cited in the text or during the prosecution of the.
`herein cited patent applications (“application cited
`documents”)——eithcr cited by the Examiner (e.g., Patent
`Office, such as the U.S. or French Patent Oflice or WIPO or
`Searching Authority) or by the applicant(s)—as well as all
`documents cited or
`referenced in application cited
`documents, are hereby incorporated herein by reference.
`Further, all documents cited herein (“herein cited
`documents”) and all documents cited or referenced in herein
`cited documents are hereby incorporated herein by refer-
`CIICC.
`
`the following documents are hereby incorpo-
`Further,
`rated herein by reference:
`
`10
`
`15
`
`20
`
`25
`
`Pat. No. 5,801,189, issued to Twinn on Sep. 1, 1998;
`U.S. Pat. No. 5,232,940, issued to Hatton on Aug. 3,
`5 1993;
`U.S. Pat. No. 5,122,530, issued to Tomioka on Jun. 16,
`1992;
`U.S. Pat. No. 5,567,429, issued to Senbo on Oct. 22,
`1996;
`U.S. Pat. No. 4,963,575, issued to Buntain on Oct. 16,
`1990;
`U.S. Pat. No. 5.516,787, issued to Takada on May 14,
`1996;
`U.S. Pat. No. 5,629,334, issued to Takada on May 13,
`1997;
`EP 0 295 117 with an international filing date of Jun. 10,
`1988;
`PCT/EP98/01224 with an international filing date of
`Mar. 1, 1998;
`PCT/EP97/06503 with an international filing date of
`Nov. 21, 1997;
`Bloomquist, J. R., Ion Channels as Targets for
`Insecticides, Annu. Rev. Entomol; Vol. 41,163—90 (1996);
`Hainzl, D. et al, Mechanisms for Selective Toxicity of
`Fzjoronil Insecticide and Its Sulfone Metabolite and Desu [fi-
`nyl Photoproduct, Chem. Res. Toxicol; Vol. 11(12), 1529-35
`(1998);
`Hainzi, D. et al, Fipmnil Insecticide: Novel Photochemi-
`cal Desulfinylation with Retention of Neumloxicity, Proc.
`Natl. Acad. Sci. USA; Nov. 12;93(23), 12764-7 (1996); and
`Cochet, P. et al, Skin Distribution of Fipronil by Microau—
`toradiography following Topical Administration to the
`Beagle Dog, Eur: J. Drug Metab. Pharmacokinet. Jul—Sep;
`22(3): 211-6 (1997).
`This invention envisions compounds, compositions, for-
`mulations and methods of use involving a phenylpyrazole as
`depicted herein or in herein cited documents; and phe-
`nylpyrazoles depicted herein or in herein cited documents
`can be used in the compositions, formulations and methods
`of herein cited patent applications. Further, the invention
`envisions compounds that degrade, e.g., biodegrade or pho-
`todegrade or chemically degrade,
`to phenylpyrazoles as
`depicted herein or in herein cited documents or to same or
`similar derivatives of phenylpyrazoles herein depicted from
`degradation (e.g., biodegradation, photodegradation,
`chemical, degradation); for instance, if a herein depicted
`phenylpyrazole degrades to compound “X”, the invention
`envisions compounds “X” and other phenylpyrazoles that
`degrade to compound “X”. The invention also envisions
`compositions, formulations, and methods of use involving
`compounds that degrade to phenylpyrazoles as depicted
`herein or in herein cited documents or to same or similar
`derivatives of phenylpyrazoles herein depicted from degra-
`dation;
`for example, pour-on formulations, spot-on
`formulations, formulations and/or methods for distribution
`in sebacious glands, formulations and/or methods of
`preventing, treating, controlling, and/or combating myasis,
`and the like, as well as in compositions, formulations, and
`uses of herein cited patent applications. (A compound that
`degrades to a phenylpyrazole herein depicted or
`that
`degrades to a same or similar derivative of a phenylpyrazole
`herein depicted from degradation, eg, a phenylpyrazole that
`degrades to compound “X” that is a degradation derivative
`of a herein depicted phenylpyrazole is herein termed a
`“pro-pp—compound”.) More in particular, herein depicted
`phenylpyrazoles as well as those of documents cited herein,
`e.g. PCI‘/EP97/06503 or WO 98/24769, which is equivalent
`to US. Pat. No. 6,265,430, degrade to the active compound
`fipronil sulfide (sulfide on the 4 position) and thus,
`the
`invention comprehends the use of phenylpyrazoles depicted
`herein and in documents cited herein that degrade to fipronil
`
`35
`
`40
`
`50
`
`60
`
`65
`
`
`
`US 6,797,724 B2
`
`3
`in for example, pour-on formulations, spot-on
`sulfide,
`formulations, formulations and/or methods for distribution
`in sebacious glands,
`formulations and/or methods of
`preventing, treating, controlling, and/or combating myasis,
`and the like, as well as in compositions, formulations, and
`uses of herein cited patent applications. Ethaprol (or a
`4-elhylsulfoxide derivative of herein depicted
`phenylpyrazole) as well as compounds of the herein formula
`wherein there is a sulfideat the 4 position and/or R1 =CN,
`SO and/or R3=CF3 or alkyl (e.g., 4—haloalkyl sulfoxide
`sulfones, 3-cyanos, 3—cyano-pro-pp-compounds) are useful,
`e.g., in pour-on formulations and methods. Formulations,
`compositions and methods of use can include an additional
`active ingredient, such as a rnacrolide antibiotic and/or an
`insect growth regulator (IGR), or the like, which can be
`admixed with or administered separately from, e.g.,
`sequentially, with the phenylpyrazole and/or pro-pp-
`compound (or the macrolide antibiotic and/or IGR can itself,
`without the phenylpyrazole and/or pro-pp-compound, be the
`active ingredient in the formulation, such as pour-on or
`spot-on formulation or a formulation for distribution in the
`sebacious glands, as disclosed herein arm herein cited patent
`applications). These and other embodiments are provided in
`this text.
`The present invention relates to a direct pour-on skin
`solution which contains an antiparasitic product and is
`intended to be applied topically to cattle and sheep.
`The invention also relates to the use of antiparasitic
`compounds for the preparation of this skin solution, as well
`as to a treatment process relating thereto.
`Cattle and sheep are affected by a large number of
`parasites.
`The main ones are ticks of the genus Boophilus, among
`which mention may be made of the species microplus (cattle
`tick), decolaratus and zznulatus.
`The other main parasites of cattle and sheep are indicated
`in order of decreasing importance:
`myiases such as Dermatobia hominis (known as Beme in
`Brazil) and Cochlyomia hominivorax (greenbottle);
`sheep myiases such asLucilia sericata, Lucilia cuprina
`(known as blowfly strike inAustralia, New Zealand and
`South Africa). These are flies whose larva constitutes
`the animal parasite.
`flies proper, namely those whose adult constitutes the
`parasite, such as Hzzemalobia irritrms (horn fly).
`lice such as Linognathus vitulorum, etc.
`galls such as Sm-coptes scabiei and Psoroptes ovis.
`Ticks, in particular Baophilus microplus, are very closely
`attached to the pasture in which they live and are particularly
`diflicult to control.
`There is at the present time no truly elfective method for
`controlling ticks, and less still an eflfective way of control-
`ling the set of parasites indicated above.
`WO-A-87/3781, EP-A-295,117 and EP-A-500,209
`describe a class of insecticides which are N—phenyl-pyrazole
`derivatives. These compounds are given as having activity
`against a very large number of parasites, including Boophi-
`Ius microplus, in fields as varied as agriculture, public health
`and veterinary medicine. The general
`teaching of these
`documents indicates that these insecticidal compounds may
`be administered via different routes; oral, parenteral, percu-
`taneous and topical
`routes. Topical administration
`comprises,
`in particular, oral formulations, baits, dietary
`supplements, skin solutions (pour-on), solutions for spray-
`ing (sprays), baths, showers,
`jets, powders, greases,
`shampoos, creams, etc. The pour-on type skin solutions are
`designed for percutancous administration. Example 9 of
`EP-A-295,117 and Example 291 of EP-A—500,209 describe
`a pour-on type skin solution containing 15% insecticide and
`85% dimethyl sulphoxide, for percutaneous administration
`of the insecticide.
`
`10
`
`15
`
`20
`
`30
`
`35
`
`40
`
`45
`
`50
`
`55
`
`60
`
`65
`
`4
`EP-A-296,381 also describes pyrazole compounds having
`insecticidal activity in the field of agriculture, public health
`and veterinary medicine. Boophilus microplus is one of the
`very many targets mentioned. There are very many forms of
`administration here also, and these include, for example,
`solutions, emulsions, suspensions, powders, pastes, granules
`and aerosols.
`The problem which is posed is to find an effective means
`which is entirely suitable for controlling the, parasites of
`cattle and sheep, in particular ticks, most particularly Boo-
`philus microplus in cattle and in particular lice and blowfly
`in sheep, under the conditions in which these animals are
`reared
`The Applicant has found that it is possible to effectively
`control Boophilus microplus for cattle using a specific
`topical formulation. The Applicant has also found that this
`formulation is effective against sheep lice and sheep flies
`known as “blowfly”,
`The aim of the present invention is thus to provide a novel
`composition which is entirely effective against Boophilus
`microplus and also against all of the other parasites
`described above such as,
`in particular, sheep lice and
`“blowfly”, this composition being entirely suitable for con-
`trolling these parasites under the conditions in which these
`animals are reared.
`Another aim of the invention is to provide such a formu-
`lation which has a long period of eflicacy, preferably longer
`than or equal to two months.
`Another aim of the invention is to provide such a formu-
`lation which is quick and easy to use and entirely compatible
`with use on herds or flocks containing a large number of
`animals.
`Another aim of the invention is to provide such a formu-
`lation which is particularly suitable for extensive pasture
`rearing and for use intended to protect animals during the
`period of rounding up and finishing (Feed Lot in USA),
`namely the final period of rearing in which a large number
`of animals are herded into a small enclosure over an averag
`period of two months preceding slaughter.
`'
`The subject of the present
`invention is thus a direct
`pour-on skin solution, intended to eliminate parasites from
`cattle and sheep, most particularly ticks, especially Boophi-
`lus microplus in cattle and lice and blowfly in sheep,
`comprising from 0.05 to 25% weight/volume, relative to the
`total solution, of a compound of formula (I)
`
`(1)
`
`in which:
`
`R] is CN or methyl or a halogen atom;
`R, is S(O),,R3 or 4,5-dicyanoimidazol-2-yl or haloalkyl;
`R3 is alkyl or haloalkyl;
`R4 represents a hydrogen or halogen atom; or a radical
`NRSRSR5, S(O),,,R7, C(O)R7, C(0)O—R7, alkyl, haloalkyl
`or OR8, or a radical —N=C (R9) (Rm);
`R5 and R6 independently represent a hydrogen atom or an
`alkyl, haloalkyl, C(O)alkyl, alkoxycarbonyl or S(O),CF3
`radical; or R5 and R5 may together form a divalent alkylene
`
`
`
`US 6,797,724 B2
`
`5
`radical which may be interrupted by one or two divalent
`hetero atoms, such as oxygen or sulphur;
`R7 represents an alkyl or haloalkyl radical;
`R3 represents an alkyl or haloalkyl radical or a hydrogen
`atom;
`R9 represents an alkyl radical or a hydrogen atom;
`R10 represents a phenyl or heteroaryl group optionally
`substituted with one or more halogen atoms or groups such
`as OH, —O—alkyl, —S-alkyl, cyano or alkyl;
`R11 and R12 represent, independently of each other, a
`hydrogen or halogen atom, or optionally CN or N02;
`R13 represents a halogen atom or a haloalkyl, haloalkoxy,
`S(O)qCF3 or SF5 group;
`in, n, q, and r represent, independently of each other, an
`integer equal to 0, 1 or 2;
`X represents a trivalent nitrogen atom or a radical
`C——-R 12, the other three valency positions of the carbon atom
`forming part of the aromatic ring;
`with the proviso that, when R1 is methyl, either R3 is
`haloalkyl, R4 is N}-l2, R11 is Cl, R13 is CF3 and X is N;
`or R2 is 4,5-dicyanoimidazol-2-yl, R, is Cl, R11 is Cl,
`R13 is CF3 and X is =C—Cl;
`in a formulation at low volume, designed to release the
`compound (1) onto the skin and the hairs for a contact
`action against parasites.
`Preferably, in formula (I), R1 is CN or methyl;
`R2 is S(O),,R3;
`R3 is alkyl or haloalkyl;
`R4 represents a hydrogen or halogen atom; or a radical
`NRSRE, S(O),,,R7, C(O)R,, alkyl, haloalkyl or ORB or a
`radical —N=C (R9) (R10);
`R3 and R6 independently represent a hydrogen atom or an
`alkyl, haloalkyl, C(O)a1kyl or S(O),CF3 radical; or R3 and
`R5 may together form a divalent alkylene radical which may
`be interrupted by one or two divalent hetero atoms, such as
`oxygen or sulphur;
`R7 represents an alkyl or haloalkyl radical;
`R8 represents an alkyl or haloalkyl radical or a hydrogen
`atom;
`R9 represents an alkyl radical or a hydrogen atom;
`R10 represents a phenyl or hetcroaryl group optionally
`substituted with one or more halogen atoms or groups such
`as OH, ——O—alkyl, —S-alkyl, cyano or alkyl;
`R11 and R12 represent, independently of each other, a
`hydrogen or halogen atom;
`R13 represents a halogen atom or a haloalkyl, haloalkoxy,
`S(O)qCF3 or SF3. group;
`m, n, q, and r represent, independently of each other, an
`integer equal to 0, 1 or 2;
`radical
`a
`X represents a trivalent nitrogen atom or
`C——R12, the other three valency positions of the carbon atom
`forming part of the aromatic ring;
`then R3 is
`with the proviso that, when R1 is methyl,
`haloalkyl, R4 is NH2, R11 is Cl, R13 is CF3 and X is N.
`However, low concentrations of from 0.05 to 10% weight/
`volume, more particularly from 0.1 to 2%, are preferred.
`Optimally, the value is between 0.25 and 1.5%, in particular
`in the region of 1%.
`The expression pour-on skin solution is understood to
`refer to a ready-to-use solution intended to be applied
`topically and locally on the animal, Preferably on the
`animal’s back and at several points or along the line of the
`back, and applied in low volume, preferably of5 to 20 ml per
`100 kg, preferably about 10 ml per 100 kg, with a total
`volume of from 10 to 150 ml per animal, preferably limited
`to 50 ml.
`
`6
`the parasite
`The compound acts by simple contact,
`becoming impregnated with the compound on contact with
`the hairs and the skin.
`
`in a noteworthy manner, a both
`This thereby affords,
`perfect compatibility with the restrictions of use in extensive
`grazing, in terms of ease of use in particular, and a spectrum
`of activity and of eflicacy, as well as a period of eflicacy,
`which are suited to this type of rearing.
`By working on the concentration of compound (I), in
`particular of compound A, solutions having note-worthy
`activities are obtained with, in particular, two months of
`eflicacy against Boophilus microplus,
`this result never
`before having been achieved. Moreover, the solution accord-
`ing to the invention allows Boophilt/.9 microplus to be totally
`eliminated from an infested animal in less than 2 days.
`As has been stated above, the solution according to the
`present invention is applied topically, in low volume, to the
`animal’s back. The compound of formula (I) then diffuses
`out
`in a noteworthy manner,
`this being reflected by a
`distribution of the compound over the animal’s entire body.
`It has also been observed that the animals remained pro-
`tected in the case of passage through water or exposure to
`rain.
`
`The dose of compound of formula (I) is preferably
`between 0.1 and 2 mg/kg (animal weight), preferably
`between 0.25 and 1.5 mg/kg, and in particular about 1
`mg/kg.
`The compounds of formula (I) in which R1 is CN will be
`selected most particularly. The compounds in which R2 is
`S(O),,R3, preferably with n=1, R3 preferably being CF3 or
`alkyl, for example methyl or ethyl, or alternatively n=0, R3
`preferably being CF3, as well as those in which X=C-R12,
`R12 being a halogen atom, will also be selected. The
`compounds in which R11 is a halogen atom and those in
`which R13 is haloalkyl, preferably CF3, are also preferred. In
`the context of the present invention, compounds combining
`two or more of these characteristics will advantageously be
`selected.
`Apreferred class of compounds of formula (I) consists of
`compounds such that R1 is CN, R3 is haloalkyl, preferably
`CF3, or ethyl, R4 is N]-I2, R11 and R12 are, independently of
`each other, a halogen atom, and/or R13 is haloalkyl.
`In the present invention, the alkyl radicals may contain
`generally from 1 to 6 carbon atoms. The cycle formed
`between the divalent alkylene radical representing R3 and
`R6, as well as with the nitrogen atom to which R5 and R6 are
`attached, may be generally a cycle of 5, 6 or 7 links.
`A most particularly preferred compound of the formula (I)
`in the invention is 1-[2,6—Cl2 4-CF3phenyl]3-CN 4-[SO-
`CF3]5-NH2pyrazole, referred to hereinbelow as compound
`A. This compound A will be used in particular in a propor-
`tion of from 0.1 to 2% by weight, more particularly about
`1%, relative to the total solution.
`Mention may also be made of the two compounds which
`differ from the above by the following characteristics:
`1-n-0, R3=CF3
`2-n=1, R3=ethyl.
`The compounds of formula (I) may be prepared according
`to one or other of the processes described in patent appli-
`cations W0-A—87/3781, 93/6089, 94/21606 or European
`patent application EP-A-0,295,117, or any other process
`which falls within the competence of a specialist skilled in
`the art of chemical synthesis. For the chemical preparation
`of the products of the invention, a person skilled in the art
`is considered as having at his or her disposal, inter alia, all
`the contents of “Chemical Abstracts” and the documents
`cited therein.
`
`5
`
`10
`
`15
`
`20
`
`25
`
`30
`
`35
`
`40
`
`45
`
`SO
`
`55
`
`60
`
`65
`
`
`
`US 6,797,724 B2
`
`7
`It is not departing from the scope of the present invention
`to incorporate other insecticides into the solution according
`to the present invention.
`The solutions according to the invention, which are
`advantageously oily, generally comprise a diluent or vehicle 5
`and also a solvent (organic solvent) for the compound of
`formula (I) if the latter is not soluble in the diluent.
`As organic solvent which can be used in the invention,
`mention may be made in particular of: acetyltributyl citrate,
`fatty acid esters such as the dimethyl ester, diisobutyl
`adipate, acetone, acetonitrile, benzyl alcohol, butyl diglycol,
`dimethylacetamide, dimethylformamide, dipropylene glycol
`n-butyl ether, ethanol, isopropanol, methanol, ethylene gly-
`col monoethyl ether, ethylene glycol monomethyl ether,
`monomethylacetamide, dipropylene glycol monomethyl
`ether,
`liquid polyoxyethylene glyeols, propylene glycol,
`2-pyrrolidone,
`in particular N-methylpyrrolidone, diethyl-
`ene glycol monoethyl ether, ethylene glycol and diethyl
`phthalate, or a mixture of at least two of these solvents.
`As vehicle or diluent, mention may be made in particular
`of:
`
`10
`
`15
`
`20
`
`plant oils such as soybean oil, groundnut oil, castor oil,
`corn oil, cotton oil, olive oil, grape seed oil, sunflower
`oil, etc.; mineral oils such as petrolatum, paraflin,
`silicone, etc.; aliphatic or cyclic hydrocarbons or
`alternatively, for example, medium-chain (C8 to C12 in
`particular) triglycerides.
`An emollient and/or spreading and/or film-forming agent
`will preferably be added, this agent being selected in par-
`ticular from:
`
`polyvinylpyrrolidone, polyvinyl alcohols, copolymers of
`vinyl acetate and vinylpyrrolidone, polyethylene
`glycols, benzyl alcohol, mannitol, glycerol, sorbitol,
`polyoxyethylenated sorbitan esters;
`lecithin, sodium
`carboxymethylcellulose, silicone oils, polydiorganosi—
`loxane oils,
`in particular polydimethylsiloxane
`(PDMS) oils, for example those containing silanol
`functionalities, or a 45V2 oil,
`anionic surfactants such as alkaline stearates, in particular
`sodium, potassium or ammonium stearates; calcium
`stearate,
`triethanolamine stearate; sodium abietate;
`alkyl sulphates,
`in particular sodium lauryl sulphate
`and
`sodium cetyl
`sulphate;
`sodium
`dodecylbenzenesulphonate, sodium dioctylsulphosuc-
`cinate; fatty acids,
`in particular those derived from
`coconut oil,
`cationic surfactants such as water-soluble quaternary
`ammonium salts of formula N*R'R"R"'R"", Y‘
`in
`which the radicals R are optionally hydroxylated
`hydrocarbon radicals and Y’ is an anion of a strong acid
`such as the halide, sulphate and sulphouate anions;
`cetyltrimethylammonium bromide is among the cat-
`ionic surfactants which can be used,
`amine salts of formula N*R'R"R‘" in which the radicals R
`are optionally hydroxylated hydrocarbon radicals; octa-
`decylamine hydrochloride is among the cationic sur-
`factants which can be used,
`nonionic surfactants such as sorbitan esters, which are
`optionally polyoxyethylenated,
`in particular polysor-
`bate 80, polyoxyethylenated alkyl ethers; polyoxypro~
`pylated fatty alcohols such as polyoxypropylene-styrol
`ether; polyethylene glycol stearate, polyoxyethylenated
`derivatives of castor oil, polyglycerol esters, polyoxy-
`ethylenated fatty alcohols, polyoxyethylenated fatty
`acids, copolymers of ethylene oxide and propylene
`oxide,
`
`30
`
`35
`
`45
`
`50
`
`S5
`
`60
`
`65
`
`8
`amphoteric surfactants such as the substituted lauryl com-
`pounds of betaine;
`or a mixture of at least two of these agents.
`The solvent will be used in proportion with the concen-
`tration of the compound I and its solubility in this solvent.
`For example, compound A has a solubility of 4.3% m/V
`in acetyl tributyl citrate. It will be sought to have the lowest
`possible volume.
`The vehicle makes up the difference to 100%.
`The emollient is preferably used in a proportion of from
`0.1 to 10%, in particular from 0.25 to 5%, by volume.
`The subject of the present invention is also a process for
`the elimination of parasites,
`in particular Boophilus
`microplus, from cattle and sheep using a direct pour-on skin
`solution according to the present invention, so as obtain
`long-lasting and broad—spectrum eflicacy, the solution being
`applied to the anirnal’s back, preferably along the line of the
`back at one or more points.
`According to a first embodiment, the process consists in
`applying the solution to the animals in pasture and/or before
`they arrive in pasture,
`the application preferably being
`repeated every month, preferably every two months.
`According to a second embodiment, the process consists
`in applying the solution to the animals before they arrive in
`the “feed Let”, it being possible for this application to be the
`final one before the animals are slaughtered.
`Obviously,
`the process may also consist in combining
`these two embodiments, namely the first followed by the
`second.
`In all cases, the ellicacy advantageously makes it possible
`to stop any application 1 to 3 months before slaughter, in
`particular between 1.5 and 2.5 months, more particularly
`about two months before slaughter.
`The solutions according to the invention may be applied
`using any means known per se, preferably using an appli-
`cator gun or a metering flask.
`in
`The aim of the method is not therapeutic and is,
`particular, to cleanse the skin and the hairs of the animals by
`eliminating the parasites which are present thereon, as well
`as their residues and dejections. The result of this is that the
`animals are no longer stressed by the parasites and their
`bites, this having positive consequences, for example on
`their growth and on the use of their food ration.
`Another subject of the invention is a therapeutic method
`using the external device according to the invention,
`intended for the treatment and prevention of parasitoses
`having pathogenic consequences.
`The subject of the present invention is also the use of the
`compounds I, in particular compound A, for the manufacture
`of a direct pour-on skin solution comprising the compound
`(I) in a low volume and designed to release the compound
`(1) onto the skin and the hairs for a contact action against the
`parasites of cattle and sheep, in particular cattle ticks, such
`as Boophilus micmplus, and sheep blowfly and lice.
`The use according to the invention is directed towards
`producing skin solutions as described above.
`The present invention will now be described in greater
`detail with the aid of non-limiting embodiment examples
`which demonstrate the activity of the solutions according to
`the present invention, with reference to the attached draw-
`ings in which:
`FIG. 1 is a graph showing the efiicacy, against Boophilus
`microplus, of skin solutions according to the invention, with
`a 0.25%, 0.5% and 1% content, relative to a control, this
`graph including, on the x-axis,
`the time in days after
`application of the skin solutions, and, on the y-axis to the
`left, the number of ticks counted on the animals on which the
`
`
`
`US 6,797,724 B2
`
`10
`The following table indicates the values recorded, the
`weight of the animals and the dose of skin solution or of
`placebo which will be applied to each of these animals.
`
`
`
`Animal No.
`94
`43
`47
`39
`34
`99
`48
`45
`40
`92
`41
`36
`96
`44
`93
`97
`
`Number of Weight
`ticks
`(in kg)
`538
`134
`470
`140
`300
`154
`254
`160
`706
`145
`452
`143
`375
`114
`201
`153
`510
`148
`453
`144
`432
`155
`236
`171
`627
`150
`482
`144
`315
`140
`292
`172
`
`Dose
`13.4
`14.0 '
`15.4
`16.0
`14.5
`14.3
`11.4
`15.3
`14.8
`14.4
`15.5
`17.1
`15.0
`14.4
`14.0
`17.2
`
`Group
`1.00%
`
`0.50%
`
`0.25%
`
`Placebo
`
`9
`slcin solutions according to the invention are applied, and, on
`the y—axis to the right, the number of ticks counted in the
`controls;
`FIG. 2 is a graph showing the population of ticks in
`animals which have received the placebo according to
`Example 2, with, on the x-axis, the time in days, and, on the
`y-axis, the number of ticks; and
`FIG. 3 compares the eficacy of a skin solution according
`to the invention containing 1% compound A (solid circles)
`with a skin solution containing 1% flumethrin (rings), with,
`on the x-axis,
`the time in days, and, on the y-axis, the
`number of ticks.
`
`EXAMPLE 1
`
`Preparation of the Solutions According to the
`Invention
`
`
`
`Ingredient
`
`Compound A
`polyoxypropylene 15 stearyl ether
`acetyl tributyl citrate
`soybean oil
`
`x - 0.25 g for 0.25% solution
`X - 0.5 g for 0.5% solution
`x - 1 g for 1% solution
`
`Function
`
`active substance
`emollient
`solvent
`diluent
`
`Amount
`
`x g
`5 g
`30 g
`qs 100 ml
`
`x-0.25 g for 0.25% solution
`x-0.5 g for 0.5% solution
`x=1 g for 1% solution
`Compound A is dissolved in the solvent before being
`mixed with the other ingredients.
`
`EXAMPLE 2
`
`Study of the efficacy of skin solutions according to the
`invention containing, respectively, 0.25, 0.50 and 1% com-
`pound A to combat Baophilus microplus.
`The study was performed on 16 young male castrated
`Herefords (weight ranging between 114 and 172 kg).
`Three skin solutions according to Example 1 were pre-
`pared:
`1. 1% compound A
`2. 0.5% compound A
`3. 0.25% compound A
`A placebo was prepared, which differed from the skin
`solutions according to the inv
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ ChargeStill Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site